Uzm. Dr. Şaban Seçmeler
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 5 publicationsSource: OpenAlex / PubMed MeSHView publications
- Colorectal Neoplasms 3 publications
- Stomach Neoplasms 3 publications
- Carcinoma, Non-Small-Cell Lung 2 publications
- Lung Neoplasms 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.
- Meme kanseri
- Akciğer kanseri
- Gastrointestinal kanserler
- Prostat kanseri
- Baş boyun kanseri
- Sarkom tedavileri
- Nadir tümörler
- Ürogenital kanserler
CV
Education and experience
Experience
- 2012-2017Haseki Eğitim Araştırma Hastanesi - İç Hastalıklarımedicalpark.com.tr
- 2017Kanuni Sultan Süleyman Eğitim Ve Araştırma Hastanesi İç Hastalıkları - Uzm. Dr.medicalpark.com.tr
- 2017-2021Prof. Dr. Cemil Taşçıoğlu Şehir Hastanesi - Tıbbı Onkolojimedicalpark.com.tr
- 2021-2022Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi - Tıbbı Onkoloji Uzm. Dr.medicalpark.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologymedicalpark.com.trFrom source
- Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
- InstitutionMedical Park Bahçelievlermedicalpark.com.trFrom source
- Area of workBreast NeoplasmsExtracted from 5 publications · Model version —From source
- Publications41 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0001-8421-9234ORCIDFrom source
- Last synchronised4 November 2026 20:55https://www.medicalpark.com.tr/hekimler/saban-secmelermedicalpark.com.tr
Scientific work
Publications on Breast Neoplasms
-
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
BMC Cancer, 2026
DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex
-
AI-augmented pharmacovigilance for cardio-oncology: FDR- controlled disproportionality and anomaly detection of antineoplastic-associated cardiac events in FAERS (2015 Q1–2025 Q4)
Research Square, 2026
DOI 10.21203/rs.3.rs-8961206/v1 Open-access full textSource: OpenAlex
-
Radiation-Induced Pleomorphic Dermal Sarcoma of the Chest Wall 25 Years After Breast Cancer Radiotherapy: A Case Report and Literature Review
Cureus, 2026
DOI 10.7759/cureus.112878 PMID 42605482 Open-access full textSource: OpenAlex
-
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study
Scientific Reports, 2025
DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 citation (Europe PMC) Open-access full textSource: OpenAlex
-
Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression
Cancer Management and Research, 2025
DOI 10.2147/cmar.s531276 PMID 40861079 1 citation (Europe PMC) Open-access full textSource: OpenAlex
-
Detecting subclinical cardiotoxicity during immune checkpoint inhibitor therapy: a combined GLS and ECG repolarization analysis.
Frontiers in oncology, 2025
DOI 10.3389/fonc.2025.1615209 PMID 40697379 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
BMC Cancer, 2024
DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome
Indian Journal of Cancer, 2024
DOI 10.4103/ijc.ijc_1283_20 PMID 39960699 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim
Akademisyen Kitabevi eBooks, 2024
DOI 10.37609/akya.2380 Open-access full textSource: OpenAlex
-
Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer
Medicine, 2024
DOI 10.1097/md.0000000000040649 PMID 39809199 4 citations (Europe PMC) Open-access full textSource: OpenAlex